Sec Form 13G Filing - LF Woodford Equity Income Fund filing for Autolus Therapeutics plcAutolus Therapeutics plc - 2019-10-09

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

Final Amendment (Amendment No. 3)*

 

Autolus Therapeutics plc

(Name of Issuer)

 

American Depositary Shares and Ordinary Shares, nominal value $0.000042 per share

(Title of Class of Securities)

 

05280R 100**

(CUSIP Number)

 

September 30, 2019

 

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)

 

Rule 13d-1(c)

 

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

** There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 05280R 100 has been assigned to the American Depositary Shares of the Company, which are quoted on the Nasdaq Global Select Market under the symbol “AUTL.” Each American Depositary Share represents 1 Ordinary Share.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP NO. 05280R 100 SCHEDULE 13G Page 2 of 6

 

1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

LF Woodford Equity Income Fund

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐                               
(b) ☒                               

 

3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United Kingdom

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON WITH

5

SOLE VOTING POWER

 

0 Ordinary Shares, nominal value $0.000042 per share (“Ordinary Shares”)

6

SHARED VOTING POWER

 

0 Ordinary Shares

7

SOLE DISPOSITIVE POWER

 

0 Ordinary Shares

8

SHARED DISPOSITIVE POWER

    
0 Ordinary Shares

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

0 Ordinary Shares

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ☐

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.0%

12

TYPE OF REPORTING PERSON

 

FI

 

 

 

 

CUSIP NO. 05280R 100 SCHEDULE 13G Page 3 of 6

 

This Amendment No. 3 amends and restates in its entirety the Schedule 13G filed by LF Woodford Equity Income Fund (the “Woodford Fund”) on July 10, 2018, as amended by Amendment No. 1 thereto on September 13, 2018 and Amendment No. 2 thereto on February 14, 2019 (as amended and restated, this “Schedule 13G”). This Amendment No. 3 is the final amendment to the Schedule 13G and is an exit filing.

 

Item 1(a). Name of Issuer:
   
  Autolus Therapeutics plc (the “Issuer”).

 

Item 1(b). Address of Issuer’s Principal Executive Offices:
   
 

Forest House, 58 Wood Lane

White City

  London W12 7RZ, United Kingdom

 

Items 2(a),

(b) and (c). Name of Persons Filing, Address of Principal Business Office and Citizenship:

 

This Schedule 13G is being filed by LF Woodford Equity Income Fund (the “Reporting Person”).

 

The principal business office of the Reporting Person is 9400 Garsington Road, Oxford OX4 2HN, United Kingdom. For the place of organization, see Item 4 of the cover page.

 

Item 2(d). Title of Class of Securities:

 

Ordinary Shares, nominal value $0.000042 per share (“Ordinary Shares”) represented by American Depository Shares (“ADS”), each of which represents one Ordinary Share.

 

Item 2(e). CUSIP Number:

        

There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 05280R 100 has been assigned to the ADS, which are quoted on the Nasdaq Global Select Market under the symbol “AUTL.”

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

  (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

  (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. ☐ 78c).

 

  (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

  (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

  (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

  (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

 

 

 

CUSIP NO. 05280R 100 SCHEDULE 13G Page 4 of 6

 

  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

  (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).

 

  (k)

Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: The Reporting Person is eligible to file pursuant to §240.13d-1(b)(1)(ii)(J) and is an investment company authorized and regulated by the Financial Conduct Authority of the United Kingdom which is comparable to the regulatory scheme applicable to the investment companies covered by Item 3(d) above.

 

Item 4. Ownership.

 

(a)        Amount beneficially owned:

 

As of the date of this filing, the Reporting Person has beneficial ownership of 0 Ordinary Shares.

 

(b)        Percent of class:

 

0.0%

 

(c)        Number of shares to which such person has:

 

  (i) Sole power to vote or direct the vote: 0
     
  (ii) Shared power to vote or direct the vote: 0
     
  (iii) Sole power to dispose or to direct the disposition of: 0
     
  (iv) Shared power to dispose of or direct the disposition of: 0

 

 

 

 

CUSIP NO. 05280R 100 SCHEDULE 13G Page 5 of 6

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9. Notice of Dissolution of a Group.

 

Not applicable.

 

Item 10. Certification.

 

By signing below I certify that, to the best of my knowledge and belief, (i) the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect and (ii) the foreign regulatory scheme applicable to investment companies authorized and regulated by the Financial Conduct Authority of the United Kingdom is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

 

 

 

 

CUSIP NO. 05280R 100 SCHEDULE 13G Page 6 of 6

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: October 9, 2019

 

  LF WOODFORD EQUITY INCOME FUND
  by: Woodford Investment Management Ltd, its Manager
     
  By: /s/ Chris Martin
  Name:  Chris Martin
  Title: Head of Compliance and
    Authorized Signatory

 

This Schedule 13G is being filed by the Woodford Fund. Woodford Investment Management Ltd is the Manager of the Woodford Fund, and pursuant to the Management Agreement, shares investment discretion over securities held of record by the Woodford Fund, including the Ordinary Shares and ADS previously held of record by the Woodford Fund. Mr. Neil Woodford, as the Head of Investment for the Manager and a controlling person of the Manager, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by the Manager. The filing of this Schedule 13G shall not be deemed an admission by Mr. Woodford that he was, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities previously covered by this Schedule 13G.